CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Harvard Apparatus Regenerative Technology, Inc.

HRGN
$40MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for HRGN. That does not mean none is planned.

Get an email about HRGN's next catalysts

Track Harvard Apparatus Regenerative Technology (HRGN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQSurgical & Medical Instruments & ApparatusπŸ‡ΊπŸ‡ΈNorth AmericaHOLLISTON
Drug Pipeline

Frequently asked questions

What is in Harvard Apparatus Regenerative Technology, Inc.'s drug pipeline?β†’

CatalystAlert tracks 7 drug candidates in Harvard Apparatus Regenerative Technology, Inc.'s (HRGN) pipeline across Phase 3, Phase 2. Its lead program is Testosterone (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Harvard Apparatus Regenerative Technology, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Harvard Apparatus Regenerative Technology, Inc. (HRGN) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track HRGN biotech catalysts?β†’

Add HRGN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Harvard Apparatus Regenerative Technology, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply